ZYRTEC® Clinical Data
Consistent relief from perennial allergic rhinitis (PAR) over a 4- to 8-week treatment period*1
*All studies are multicenter, randomized, placebo-controlled, double-blind, minimum 100 participants with previous diagnosis of PAR, and adequate minimum duration (4 weeks). Total symptom severity measured by patient.
Reference: 1. Data on file, Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division.
Need samples or patient resources?
See the ZYRTEC® difference
Compare ZYRTEC® vs other OTC oral antihistamines.
See the complete family of ZYRTEC® products.